AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 47 filers reported holding AGILE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | -28.6% | 5,000 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -30.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | -28.6% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $14,000 | -6.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $15,000 | +7.1% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $14,000 | +40.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | -16.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | +33.3% | 5,000 | +53.8% | 0.00% | – |
| Q1 2018 | $9,000 | 0.0% | 3,250 | 0.0% | 0.00% | – |
| Q4 2017 | $9,000 | -10.0% | 3,250 | +85.7% | 0.00% | – |
| Q4 2016 | $10,000 | – | 1,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |